Cargando…

Liver decompensation predicts ribavirin overexposure in hepatitis C virus patients treated with direct-acting antivirals

AIM: To determine whether ribavirin (RBV) concentrations differ according to cirrhosis stage among cirrhotic patients treated with interferon-free regimens. METHODS: We included patients with hepatitis C virus and cirrhosis [Child-Pugh (CP) A or B], Glomerular Filtration Rate ≥ 60 mL/min, who starte...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guardigni, Viola, Badia, Lorenzo, Conti, Matteo, Rinaldi, Matteo, Mancini, Rita, Viale, Pierluigi, Verucchi, Gabriella
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2017
Materias:	Observational Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5740096/ https://www.ncbi.nlm.nih.gov/pubmed/29290908 http://dx.doi.org/10.4254/wjh.v9.i34.1270

Ejemplares similares

Early Onset of Tenofovir-Related Fanconi Syndrome in a Child with Acute Hepatitis B: A Case Report and Systematic Review of Literature
por: Pascale, Renato, et al.
Publicado: (2017)

Out-of-Hospital Treatment of Hepatitis C Increases Retention in Care among People Who Inject Drugs and Homeless Persons: An Observational Study
por: Granozzi, Bianca, et al.
Publicado: (2021)

Outcomes assessment of hepatitis C virus-positive psoriatic patients treated using pegylated interferon in combination with ribavirin compared to new Direct-Acting Antiviral agents
por: Damiani, Giovanni, et al.
Publicado: (2018)

Long term outcome of antiviral therapy in patients with hepatitis B associated decompensated cirrhosis
por: Ju, Young-Cheol, et al.
Publicado: (2018)

Northern overexposure.
por: Tenenbaum, D J
Publicado: (1998)

Hepatitis C virus eradication with directly acting antivirals improves health-related quality of life and psychological symptoms
por: Nardelli, Silvia, et al.
Publicado: (2019)

Use of Ribavirin for Hepatitis C Treatment in the Modern Direct-acting Antiviral Era
por: Mathur, Poonam, et al.
Publicado: (2018)

Hepatitis C Direct Acting Antivirals and Ribavirin Modify Lipid but not Glucose Parameters
por: Doyle, Mary-Anne, et al.
Publicado: (2019)

Effect of treating chronic hepatitis C with direct-acting antivirals on extrahepatic cutaneous manifestations
por: El Kassas, Mohamed, et al.
Publicado: (2020)

Effectiveness and safety of generic and brand direct acting antivirals for treatment of chronic hepatitis C
por: Abdulla, Maheeba, et al.
Publicado: (2022)

Ribavirin revisited in the era of direct‐acting antiviral therapy for hepatitis C virus infection
por: Feld, Jordan J., et al.
Publicado: (2016)

Mercury overexposure and atrial fibrillation
por: Guzzi, Gianpaolo, et al.
Publicado: (2016)

M2BPGi for assessing liver fibrosis in patients with hepatitis C treated with direct-acting antivirals
por: Saleh, Shereen A, et al.
Publicado: (2020)

Real-world effectiveness and safety of direct-acting antivirals in hepatitis C virus patients with mental disorders
por: Dybowska, Dorota, et al.
Publicado: (2023)

Sofosbuvir and ribavirin in acute hepatitis C–infected patient with decompensated cirrhosis
por: Liu, Hui, et al.
Publicado: (2016)

Safety and efficacy of tenofovir in chronic hepatitis B-related decompensated cirrhosis
por: Lee, Soon Kyu, et al.
Publicado: (2017)

Hepatitis C virus therapy with peg-interferon and ribavirin in Myanmar: A resource-constrained country
por: Hlaing, Naomi Khaing Than, et al.
Publicado: (2016)

Efficacy and safety of combined directly acting antivirals for treatment of Chinese chronic hepatitis C patients in a real-world setting
por: Chen, Jian-Hong, et al.
Publicado: (2017)

Hepatocellular carcinoma, decompensation, and mortality based on hepatitis C treatment: A prospective cohort study
por: Choi, Gwang Hyeon, et al.
Publicado: (2022)

Real-world effectiveness of direct-acting antivirals in people living with human immunodeficiency virus and hepatitis C virus genotype 6 infections
por: Sun, Hsin-Yun, et al.
Publicado: (2022)

Hepatitis C virus related cirrhosis decreased as indication to liver transplantation since the introduction of direct-acting antivirals: A single-center study
por: Ferrarese, Alberto, et al.
Publicado: (2018)

Defining Physiological Decompensation: An Expert Consensus and Retrospective Outcome Validation
por: Mitchell, Oscar J. L., et al.
Publicado: (2022)

Genistein Targets STING-Driven Antiviral Responses
por: Ullah, Tomalika R., et al.
Publicado: (2022)

Medication beliefs predict medication adherence in ambulatory patients with decompensated cirrhosis
por: Hayward, Kelly L, et al.
Publicado: (2017)

COVID-19 in patients with HIV-1 infection: a single-centre experience in northern Italy
por: Calza, Leonardo, et al.
Publicado: (2020)

Real life efficacy and safety of direct-acting antiviral therapy for treatment of patients infected with hepatitis C virus genotypes 1, 2 and 3 in northwest China
por: Yang, Ying, et al.
Publicado: (2019)

Elevated calprotectin levels are associated with mortality in patients with acute decompensation of liver cirrhosis
por: Matiollo, Camila, et al.
Publicado: (2022)

Immunological Predictors of Nonresponse to Directly Acting Antiviral Therapy in Patients With Chronic Hepatitis C and Decompensated Cirrhosis
por: Childs, Kate, et al.
Publicado: (2017)

With professional overexposure, how to protect yourself from litigation?
por: Artese, Flávia
Publicado: (2018)

Connexin-Dependent Transfer of cGAMP to Phagocytes Modulates Antiviral Responses
por: Pépin, Geneviève, et al.
Publicado: (2020)

Efficacy and Safety of Sofosbuvir/Velpatasvir Plus Ribavirin in Patients with Hepatitis C Virus-Related Decompensated Cirrhosis
por: Flamm, Steven, et al.
Publicado: (2023)

Neonatal overfeeding induced glucocorticoid overexposure accelerates hepatic lipogenesis in male rats
por: Yang, Fan, et al.
Publicado: (2018)

Prevalence and clinical characteristics of autoimmune liver disease in hospitalized patients with cirrhosis and acute decompensation in China
por: Shen, Zi-Xuan, et al.
Publicado: (2022)

In vivo nose-to-brain delivery of the hydrophilic antiviral ribavirin by microparticle agglomerates
por: Giuliani, Alessandro, et al.
Publicado: (2018)

Topoisomerase 1 Inhibition Promotes Cyclic GMP-AMP Synthase-Dependent Antiviral Responses
por: Pépin, Geneviève, et al.
Publicado: (2017)

Sofosbuvir–velpatasvir plus ribavirin in Japanese patients with genotype 1 or 2 hepatitis C who failed direct-acting antivirals
por: Izumi, Namiki, et al.
Publicado: (2018)

A new model to predict response to direct-acting antiviral therapy in decompensated cirrhotics due to hepatitis C virus
por: Debnath, Prasanta, et al.
Publicado: (2020)

Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2
por: Busnadiego, Idoia, et al.
Publicado: (2020)

Antiviral Efficacy of Ribavirin and Favipiravir against Hantaan Virus
por: Mayor, Jennifer, et al.
Publicado: (2021)

Negative-index gratings formed by femtosecond laser overexposure and thermal regeneration
por: He, Jun, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ph9eqlre1l03kaore5gnug596h